High RiskDepression / Major Depressive DisorderAnxiety DiseaseObsessive - Compulsive Disorder
Study summary
This prospective observational cohort study will enroll approximately 200 children and adolescents aged 7-17 years who are at elevated risk for common mental disorders, including depressive disorders, anxiety disorders, and obsessive-compulsive disorder, based on family history or subthreshold emotional or behavioral symptoms. Participants will be followed for two years. Clinical assessments, questionnaires, EEG, biological samples, and MRI will be collected at scheduled intervals. The study aims to identify factors associated with the onset and progression of these disorders and support early risk identification.
Eligibility
Sex
ALL
Min age
7 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria:
1. Aged 7-17 years at enrollment.
2. Meeting at least one of the following conditions: Having at least one first-degree relative with a depressive disorder, anxiety disorder, or obsessive-compulsive disorder; or exhibiting clinically relevant but subthreshold depressive, anxiety, obsessive-compulsive, or repetitive behavioral symptoms.
3. Not meeting the full diagnostic criteria for a depressive disorder, anxiety disorder, or obsessive-compulsive disorder at baseline, as assessed using the K-SADS-PL.
4. Willing and able to participate in the scheduled assessments and follow-up visits.
5. Written informed consent provided by a parent or legal guardian and assent provided by the participant
Exclusion Criteria:
1. A current or previous diagnosis of a depressive disorder, anxiety disorder, or obsessive-compulsive disorder.
2. A severe psychiatric condition requiring immediate clinical intervention, including acute suicide risk, a psychotic disorder, or a bipolar disorder.
3. A major neurological disorder, severe head injury, or serious or unstable medical condition that may interfere with study participation.
4. Intellectual or cognitive impairment that prevents the participant from understanding or completing the study assessments.
5. Inability or unwillingness of the participant or legal guardian to comply with the study procedures.
Primary outcome measure(s)
Cumulative Incidence of Depressive Disorders, Anxiety Disorders, or Obsessive-Compulsive Disorder — From baseline through 24 months The proportion of participants who newly meet the diagnostic criteria for at least one depressive disorder, anxiety disorder, or obsessive-compulsive disorder during follow-up, as determined using the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL).
Trial sites (1)
Facility
City
Region
Status
Shanghai Mental Health Center
Shanghai
China
More Shanghai Mental Health Center trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.